nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acquired Perforating Dermatosis and Dermatology Life Quality Index in Patients Receiving hemodialysis.
|
Roldan-Contreras, Sonia Estrella |
|
|
44 |
2 |
p. 251-255 |
artikel |
2 |
Acute interstitial nephritis following COVID-19 vaccination
|
Kleebayoon, Amnuay |
|
|
44 |
2 |
p. 312 |
artikel |
3 |
A renal failure related to the feline world
|
Cavada-Bustamante, Adriana M. |
|
|
44 |
2 |
p. 308-310 |
artikel |
4 |
Association of aortic stiffness with abdominal vascular and coronary calcifications in patients with stage 3 and 4 chronic kidney disease
|
Hidalgo Santiago, Juan Carlos |
|
|
44 |
2 |
p. 256-267 |
artikel |
5 |
Compassionate use of tolvaptan in acquired megacolon secondary to autosomal dominant polycystic kidney disease (ADPKD)
|
Viejo Boyano, Iris |
|
|
44 |
2 |
p. 301-303 |
artikel |
6 |
COVID 19 and myoclonus, do hemodialysis patients have more risk?
|
Pol Heres, Salia Virxinia |
|
|
44 |
2 |
p. 284-286 |
artikel |
7 |
Cryoglobulinemic vasculitis and membranoproliferative glomerulonephritis in a patient with cured virus C infection
|
Sagrado, Ester Casillas |
|
|
44 |
2 |
p. 295-297 |
artikel |
8 |
Decision making – Should we perform kidney transplantation on a patient with a positive RT-PCR test for SARS-CoV-2?
|
Francisco, Diogo |
|
|
44 |
2 |
p. 297-299 |
artikel |
9 |
De novo IgA nephropathy in a kidney transplant recipient after SARS-CoV-2 vaccination
|
Alonso, M. |
|
|
44 |
2 |
p. 277-279 |
artikel |
10 |
Dysregulation of ferroptosis may participate in the mitigating effect of CoCl2 on contrast-induced nephropathy
|
Li, Huilin |
|
|
44 |
2 |
p. 180-193 |
artikel |
11 |
Effect of SGLT2 inhibitors on anemia and their possible clinical implications
|
Cases, Aleix |
|
|
44 |
2 |
p. 165-172 |
artikel |
12 |
Expression of JC virus in a kidney transplant recipient with renal cell carcinoma
|
Garayeva, Nurana |
|
|
44 |
2 |
p. 288-289 |
artikel |
13 |
Familial hypomagnesemia with hipercalciuria and nephrocalcinosis associated with sensorineural hearing loss
|
Burgos Martín, J. |
|
|
44 |
2 |
p. 281-283 |
artikel |
14 |
Hypochloremia associated with a greater incidence of pneumonia in chronic hemodialysis patients with COVID-19: a center's experience
|
Valga, Francisco |
|
|
44 |
2 |
p. 290-292 |
artikel |
15 |
Hypouricemia with hypercalciuria: Longitudinal study and review of the topic
|
Moraleda Mesa, Teresa |
|
|
44 |
2 |
p. 233-240 |
artikel |
16 |
Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk
|
Cebrian, Ana |
|
|
44 |
2 |
p. 292-294 |
artikel |
17 |
Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick?
|
Ozer, Hakan |
|
|
44 |
2 |
p. 217-223 |
artikel |
18 |
JC polyomavirus nephropathy in renal transplant patient: An uncommon guest
|
Santana Quintana, Cristo Adonay |
|
|
44 |
2 |
p. 303-305 |
artikel |
19 |
Kidney transplant with refractory hypertension in a case of mid aortic syndrome
|
Camino Ramos, S. |
|
|
44 |
2 |
p. 276-277 |
artikel |
20 |
Latent tuberculosis vs active tuberculosis in dialysis patients: lessons from an epidemiological study in orense
|
Perez, Maria Hernansanz |
|
|
44 |
2 |
p. 310-311 |
artikel |
21 |
Levotiroxin intoxication; role of extracorporeal techniques
|
Salanova Villanueva, Laura |
|
|
44 |
2 |
p. 279-281 |
artikel |
22 |
Losartan ameliorates renal fibrosis by inhibiting tumor necrosis factor signal pathway
|
Wang, Hongshuang |
|
|
44 |
2 |
p. 139-149 |
artikel |
23 |
Non-valvular atrial fibrillation in patients on peritoneal dialysis, prevalence, treatment and professionals involved
|
Perez-Bernat, Elisa |
|
|
44 |
2 |
p. 268-275 |
artikel |
24 |
Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment
|
de la Prada Álvarez, Francisco José |
|
|
44 |
2 |
p. 306-307 |
artikel |
25 |
Online hemodiafiltration without calcium replacement using citrate as an anticoagulant and dialysis fluid with 3.5 mEq of post dilutional calcium in patients with heparin-induced thrombocytopenia: Report of 2 cases
|
Ramos, Lucas |
|
|
44 |
2 |
p. 299-301 |
artikel |
26 |
Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care
|
Bover, Jordi |
|
|
44 |
2 |
p. 241-250 |
artikel |
27 |
Precision medicine: “Point of Care Ultrasound” (PoCUS) in the diagnostic approach to the patient with hyponatremia
|
Mazón Ruiz, Jaime |
|
|
44 |
2 |
p. 159-164 |
artikel |
28 |
Prognostic implication of thyroid hormones among patients with acute kidney injury
|
Choulia, Manpreet Kaur |
|
|
44 |
2 |
p. 286-288 |
artikel |
29 |
Septic acute kidney injury and gut microbiome: Should we change our approach?
|
Dicu-Andreescu, Ioana |
|
|
44 |
2 |
p. 119-128 |
artikel |
30 |
Strategies for prevention and treatment of SARS-COV-2 infection in patients with chronic kidney disease: Literature review
|
Marques Vidas, María |
|
|
44 |
2 |
p. 150-158 |
artikel |
31 |
Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action
|
Benlloch, Salvador |
|
|
44 |
2 |
p. 129-138 |
artikel |
32 |
The efficacy of fluconazole for anti-fungal prophylaxis in peritoneal dialysis patients: A systematic review and meta-analysis
|
Motta Guimarães, Maria Gabriela |
|
|
44 |
2 |
p. 173-179 |
artikel |
33 |
The urogenital microbiome in chronic kidney disease patients on peritoneal dialysis
|
Araujo, Ricardo |
|
|
44 |
2 |
p. 194-203 |
artikel |
34 |
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio
|
Vidal-Alabró, Anna |
|
|
44 |
2 |
p. 204-216 |
artikel |
35 |
Vascular calcification in peritoneal dialysis patients and its association with bone-derived molecules and bone histomorphometry
|
Pereira, Luciano |
|
|
44 |
2 |
p. 224-232 |
artikel |